DR REDDYS LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of DR REDDYS LABORATORIES have increased by 13.54% YoY .
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -79.72 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
DR REDDYS LABORATORIES Last 5 Annual Financial Results
[BOM: 500124|NSE : DRREDDY]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
| Expenses | ₹20,078 Cr | ₹18,321 Cr | ₹17,778 Cr | ₹15,178 Cr | ₹15,047 Cr |
| Operating Profit (Excl OI) | ₹7,933 Cr | ₹6,349 Cr | ₹3,767 Cr | ₹3,870 Cr | ₹2,470 Cr |
| Other Income | ₹894 Cr | ₹1,056 Cr | ₹485 Cr | ₹291 Cr | ₹621 Cr |
| Interest | ₹171 Cr | ₹143 Cr | ₹96 Cr | ₹97 Cr | ₹98 Cr |
| Depreciation | ₹1,470 Cr | ₹1,250 Cr | ₹1,165 Cr | ₹1,229 Cr | ₹1,163 Cr |
| Profit Before Tax | ₹7,201 Cr | ₹6,049 Cr | ₹3,061 Cr | ₹2,884 Cr | ₹1,886 Cr |
| Profit After Tax | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
| Consolidated Net Profit | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
| Earnings Per Share (Rs) | ₹67.81 | ₹334.41 | ₹270.55 | ₹131.16 | ₹117.28 |
| PAT Margin (%) | 17.54 | 19.91 | 18.27 | 10.13 | 10.25 |
| ROE(%) | 18.61 | 21.76 | 21.36 | 11.93 | 11.82 |
| ROCE(%) | 23.25 | 26.86 | 26.22 | 14.59 | 15.49 |
| Total Debt/Equity(x) | 0.14 | 0.07 | 0.06 | 0.18 | 0.17 |
Key Financials |
||
| Market Cap | : | ₹ 103,260.9 Cr |
| Revenue (TTM) | : | ₹ 33,519.9 Cr |
| Net Profit(TTM) | : | ₹ 5,726.7 Cr |
| EPS (TTM) | : | ₹ 68.6 |
| P/E (TTM) | : | 18.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DR REDDYS LABORATORIES | 0.2% | -6% | -4.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% | 2.3% | -11.6% |
| DIVIS LABORATORIES | 7.1% | 8.8% | 10.3% |
| CIPLA | 3.9% | -1.3% | -3.4% |
| TORRENT PHARMACEUTICALS | -1.3% | -1.3% | 2.2% |
| MANKIND PHARMA | -0.6% | -5.6% | -8.8% |
| ZYDUS LIFESCIENCES | -0.7% | -6.3% | -6% |
| LUPIN | 1.7% | -5.1% | -8.6% |
| AUROBINDO PHARMA | 5% | 2.6% | -22.4% |
DR REDDYS LABORATORIES Revenues
[BOM: 500124|NSE : DRREDDY]
| Y-o-Y | 13.54 % |
| 5 Yr CAGR | 12.45 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹28,011 Cr | 13.54 | |
| Mar2024 | ₹24,670 Cr | 14.50 | |
| Mar2023 | ₹21,545 Cr | 13.11 | |
| Mar2022 | ₹19,048 Cr | 8.74 | |
| Mar2021 | ₹17,517 Cr | - | |
DR REDDYS LABORATORIES Operating Profit
[BOM: 500124|NSE : DRREDDY]
| Y-o-Y | 24.95 % |
| 5 Yr CAGR | 33.87 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,933 Cr | 24.95 | |
| Mar2024 | ₹6,349 Cr | 68.52 | |
| Mar2023 | ₹3,767 Cr | -2.65 | |
| Mar2022 | ₹3,870 Cr | 56.65 | |
| Mar2021 | ₹2,470 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 10.02 % |
| 5 Yr CAGR | 19.05 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 28.32% | 10.02 | |
| Mar2024 | 25.74% | 47.17 | |
| Mar2023 | 17.49% | -13.93 | |
| Mar2022 | 20.32% | 44.11 | |
| Mar2021 | 14.1% | - | |
DR REDDYS LABORATORIES Profit After Tax
[BOM: 500124|NSE : DRREDDY]
| Y-o-Y | 23.75 % |
| 5 Yr CAGR | 28.81 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | -3.67 | |
| Mar2021 | ₹2,026 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -11.90 % |
| 5 Yr CAGR | 14.37 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 17.54 % | -11.90 | |
| Mar2024 | 19.91 % | 8.98 | |
| Mar2023 | 18.27 % | 80.36 | |
| Mar2022 | 10.13 % | -1.17 | |
| Mar2021 | 10.25 % | - | |
DR REDDYS LABORATORIES Earnings Per Share (EPS)
[BOM: 500124|NSE : DRREDDY]
| Y-o-Y | -79.72 % |
| 5 Yr CAGR | -12.80 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 | -79.72 | |
| Mar2024 | ₹334 | 23.60 | |
| Mar2023 | ₹271 | 106.27 | |
| Mar2022 | ₹131 | 11.83 | |
| Mar2021 | ₹117 | - | |
DR REDDYS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500124|NSE : DRREDDY]
| Y-o-Y | -13.44 % |
| 5 Yr CAGR | 10.69 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 23.25% | -13.44 | |
| Mar2024 | 26.86% | 2.44 | |
| Mar2023 | 26.22% | 79.71 | |
| Mar2022 | 14.59% | -5.81 | |
| Mar2021 | 15.49% | - | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹1,237.3 |
| Current MarketCap | : | ₹ 103,260.9 Cr |
| Updated EOD on | : | Oct 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.2% |
-6% |
-4.1% |
| SENSEX | 0.1% |
0.6% |
0.7% |
DR REDDYS LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE HEALTHCARE | 0.8% | -0.9% | -0.7% |
| BSE SENSEX NEXT 30 | 0.2% | 0.3% | -6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY HEALTHCARE INDEX | 1.2% | -0% | -1.9% |
| NIFTY PHARMA | 0.8% | -0.8% | -7.3% |
| NIFTY100 LOW VOLATILITY 30 | 0.5% | -1.6% | -2.1% |
| NIFTY50 VALUE 20 | 0.4% | 0.1% | -10.1% |
| NIFTY50 EQUAL WEIGHT | 0.2% | 0.4% | -0.4% |
You may also like the below Video Courses
FAQ about DR REDDYS LABORATORIES Financials
How the annual revenues of DR REDDYS LABORATORIES have changed ?
The Revenues of DR REDDYS LABORATORIES have increased by 13.54% YoY .
How the Earnings per Share (EPS) of DR REDDYS LABORATORIES have changed?
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -79.72 % YoY .
Check out Intrinsic Value of Peers of DR REDDYS LABORATORIES
Compare Stock Analytics of Peers of DR REDDYS LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
